Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2017, vol. 26, nr 6, September, p. 919–923

doi: 10.17219/acem/66291

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Effect of nebivolol on fracture healing: An experimental rat model

Hasan Metineren1,A,D,E,F, Turan Cihan Dülgeroğlu1,A,B,C, Mehmet Hüseyin Metineren2,A,C, Ekrem Aydın1,A,B,C

1 Department of Orthopedics and Traumatology, Medical Faculty, Dumlupınar University, Turkey

2 Department of Pathology, Medical Faculty, Dumlupınar University, Turkey

Abstract

Background. Bone metabolism is a complex system, and fracture healing is one of its most important functions. Many circumstances can influence this process. Chronic drug use in elderly populations can affect bone healing, and inadequate tissue perfusion, increased free radicals and adverse drug effects can negatively influence fracture healing. Nebivolol, an anti-hypertensive drug that selectively blocks β1 receptors, effectively reduces blood pressure by inducing peripheral vasodilation. Nebivolol also exerts anti-oxidant effects by stimulating nitric oxide (NO) synthesis. Many studies show that NO protects the vascular endothelium and improves fracture healing.
Objectives. In this study, the histological and radiological effects of intraperitoneally administered nebivolol on fracture healing were evaluated.
Material and Methods. Twenty-one Sprague Dawley rats were divided into 3 (nebivolol 1, 2 and control) groups. Sterile nebivolol solution (1 mL = 0.017 mg nebivolol) was given to the rats in group 1 every day for 4 weeks, while the rats in nebivolol group 2 were given 2 mL per day, beginning after the production of an open, displaced unilateral femur fracture. Radiographic and histological studies were used to evaluate fracture healing.
Results. Histological and immunohistochemical analysis showed osseous healing with woven bone at the fracture site and only minimal amounts of cartilage in nebivolol 1 and 2 groups. Radiological grading was not different between the control and the nebivolol groups.
Conclusion. This study suggests that nebivolol, a selective β blocker, has positive effects on fracture healing through anti-oxidative effects via the NO pathway and direct vasodilator effects.

Key words

experimental model, nitric oxide, fracture healing, nebivolol

References (20)

  1. McKibbin B. The biology of fracture healing in long bones. J Bone Joint Surg Br. 1978;60:150–162.
  2. Cornell CN, Lane JM. Newest factors in fracture healing. Clin Orthop Related Res. 1992;277:297–311.
  3. Einhorn TA, Majeska RJ, Rush EB, Levine PM, Horowitz MC. The expression of cytokine activity by fracture callus. J Bone Miner Res. 1995;10:1272–1281.
  4. Xhonneux R, Wouters L, Reneman RS, Janssen PA. The l-enantiomer of nebivolol potentiates the blood pressure lowering effect of the d-enantiomer. Eur J Pharmacol. 1990;181:261–265.
  5. Broeders MA, Doevendans PA, Bekkers BC, et al. Nebivolol: A third-generation beta-blocker that augments vascular nitric oxide release: Endothelial beta-2 adrenergic receptor-mediated nitric oxide production. Circulation. 2000;102:677–684.
  6. Troost R, Schwedhelm E, Rojczyk S, Tsikas D, Frölich JC. Nebivolol decreases systemic oxidative stress in healthy volunteers. Br J Clin Pharmacol. 2000;50:377–379.
  7. Tomlinson RE, Shoghi KI, Silva MJ. Nitric oxide-mediated vasodilation increases blood flow during the early stages of stress fracture healing. J Appl Physiol. 2014;15(116):416–424.
  8. Allen HL, Wase A, Bear WT. Indomethacin and aspirin: Effect of nonsteroidal anti-inflammatory agents on the rate of fracture repair in the rat. Acta Orthop Scand. 1980;51:595–600.
  9. Goldberg VM, Powell A, Shaffer JW, Zika J, Bos GD, Heiple KG. Bone grafting: Role of histocompatibility in transplantation. J Orthop Res. 1985;3:389–404.
  10. Xia J, Zhang Z, Wang J, Zu J, Wang N, Wang D. Comparison of the effects of heparin and the direct factor Xa inhibitor, rivaroxaban, on bone microstructure and metabolism in adult rats. Connect Tissue Res. 2015;56:477–482.
  11. Nakagami H, Osako MK, Morishita R. Potential effect of angiotensin II receptor blockade in adipose tissue and bone. Curr Pharm Des. 2013;19:3049–3053.
  12. Gao Y, Nagao T, Bond RA, Janssens WJ, Vanhoutte PM. Nebivolol induces endothelium-dependent relaxations of canine coronary arteries. J Cardiovasc Pharmacol. 1991;17:964–969.
  13. Gülcan E, Kuçuk A, Cayci K, et al. Topical effects of nebivolol on wounds in diabetic rats. Eur J Pharm Sci. 2012;47:451–455.
  14. Schaffer MR, Tantry U, Gross SS, et al. Nitric oxide regulates wound healing. J Surg Res. 1996;63:237–240.
  15. Mason RP, Kubant R, Jacob RF. Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: Role of antioxidant activity. J Cardiovasc Pharmacol. 2006;48:862–869.
  16. Pettersson K, Bejne B, Bj­­örk H, Strawn WB, Bondjers G. Experimental sympathetic activation causes endothelial injury in the rabbit thoracic aorta via beta 1-adrenoceptor activation. Circ Res. 1990;67:1027–1034.
  17. Fedorchenko IL, Nebieridze DV, Safarian AS, Skripnikova IA, Sobchenko KE. Cardiovascular diseases and osteoporosis: What is common? Ter Arkh. 2014;86:116–119.
  18. Mollnau H, Schulz E, Daiber A, et al. Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells. Arterioscler Thromb Vasc Biol. 2003;23:615–621.
  19. Turner CH, Takano Y, Owan I, Murrell GA. Nitric oxide inhibitor L-NAME suppresses mechanically induced bone formation in rats. Am J Physiol. 1996;270:634–639.
  20. Diwan AD, Wang MX, Jang D, Zhu W, Murrell GA. Nitric oxide modulates fracture healing. J Bone Miner Res. 2000;15:342–351.
© Wroclaw Medical University